{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["CXCL1", "airway hyperresponsiveness", "gastrin-releasing peptide receptor", "microarray", "neutrophil"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "28957638", "DateCompleted": {"Year": "2018", "Month": "07", "Day": "06"}, "DateRevised": {"Year": "2019", "Month": "03", "Day": "01"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": ["10.1165/rcmb.2017-0071OC"], "Journal": {"ISSN": "1535-4989", "JournalIssue": {"Volume": "58", "Issue": "3", "PubDate": {"Year": "2018", "Month": "Mar"}}, "Title": "American journal of respiratory cell and molecular biology", "ISOAbbreviation": "Am J Respir Cell Mol Biol"}, "ArticleTitle": "Augmented Responses to Ozone in Obese Mice Require IL-17A and Gastrin-Releasing Peptide.", "Pagination": {"StartPage": "341", "EndPage": "351", "MedlinePgn": "341-351"}, "Abstract": {"AbstractText": ["Ozone and obesity both increase IL-17A in the lungs. In mice, obesity augments the airway hyperresponsiveness and neutrophil recruitment induced by acute ozone exposure. Therefore, we examined the role of IL-17A in obesity-related increases in the response to ozone observed in obese mice. Lean wild-type and obese db/db mice were pretreated with IL-17A-blocking or isotype antibodies, exposed to air or ozone (2 ppm for 3 h), and evaluated 24 hours later. Microarray analysis of lung tissue gene expression was used to examine the mechanistic basis for effects of anti-IL-17A. Compared with lean mice, ozone-exposed obese mice had greater concentrations of BAL IL-17A and greater numbers of pulmonary IL-17A<sup>+</sup> cells. Ozone-induced increases in BAL IL-23 and CCL20, cytokines important for IL-17A<sup>+</sup> cell recruitment and activation, were also greater in obese mice. Anti-IL-17A treatment reduced ozone-induced airway hyperresponsiveness toward levels observed in lean mice. Anti-IL-17A treatment also reduced BAL neutrophils in both lean and obese mice, possibly because of reductions in CXCL1. Microarray analysis identified gastrin-releasing peptide (GRP) receptor (Grpr) among those genes that were both elevated in the lungs of obese mice after ozone exposure and reduced after anti-IL-17A treatment. Furthermore, ozone exposure increased BAL GRP to a greater extent in obese than in lean mice, and GRP-neutralizing antibody treatment reduced obesity-related increases in ozone-induced airway hyperresponsiveness and neutrophil recruitment. Our data indicate that IL-17A contributes to augmented responses to ozone in db/db mice. Furthermore, IL-17A appears to act at least in part by inducing expression of Grpr."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Department of Environmental Health and."}], "LastName": "Mathews", "ForeName": "Joel A", "Initials": "JA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "2 Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Massachusetts."}], "LastName": "Krishnamoorthy", "ForeName": "Nandini", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Department of Environmental Health and."}], "LastName": "Kasahara", "ForeName": "David I", "Initials": "DI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "3 Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts."}], "LastName": "Hutchinson", "ForeName": "John", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Department of Environmental Health and."}], "LastName": "Cho", "ForeName": "Youngji", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Department of Environmental Health and."}], "LastName": "Brand", "ForeName": "Jeffrey D", "Initials": "JD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Department of Environmental Health and."}], "LastName": "Williams", "ForeName": "Alison S", "Initials": "AS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Department of Environmental Health and."}], "LastName": "Wurmbrand", "ForeName": "Allison P", "Initials": "AP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Department of Environmental Health and."}], "LastName": "Ribeiro", "ForeName": "Luiza", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "4 Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; and."}], "LastName": "Cuttitta", "ForeName": "Frank", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "5 Department of Pathology, Duke University Medical Center, Durham, North Carolina."}], "LastName": "Sunday", "ForeName": "Mary E", "Initials": "ME"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "2 Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Massachusetts."}], "LastName": "Levy", "ForeName": "Bruce D", "Initials": "BD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Department of Environmental Health and."}], "LastName": "Shore", "ForeName": "Stephanie A", "Initials": "SA"}], "GrantList": [{"GrantID": "P30 ES000002", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 ES013307", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "F32 ES022556", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL122531", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "T32 HL007118", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "R21 ES024032", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Respir Cell Mol Biol", "NlmUniqueID": "8917225", "ISSNLinking": "1044-1549"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antibodies, Blocking"}, {"RegistryNumber": "0", "NameOfSubstance": "CCL20 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Chemokine CCL20"}, {"RegistryNumber": "0", "NameOfSubstance": "Chemokine CXCL1"}, {"RegistryNumber": "0", "NameOfSubstance": "Cxcl1 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Il17a protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Il23a protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-17"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-23 Subunit p19"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Bombesin"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "80043-53-4", "NameOfSubstance": "Gastrin-Releasing Peptide"}], "CommentsCorrectionsList": [{"RefSource": "doi: 10.1165/rcmb.2017-0363ED"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antibodies, Blocking"}, {"QualifierName": ["immunology"], "DescriptorName": "Chemokine CCL20"}, {"QualifierName": ["immunology"], "DescriptorName": "Chemokine CXCL1"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["immunology"], "DescriptorName": "Gastrin-Releasing Peptide"}, {"QualifierName": ["immunology"], "DescriptorName": "Interleukin-17"}, {"QualifierName": ["immunology"], "DescriptorName": "Interleukin-23 Subunit p19"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Mice, Knockout"}, {"QualifierName": ["immunology"], "DescriptorName": "Neutrophil Infiltration"}, {"QualifierName": ["immunology"], "DescriptorName": "Neutrophils"}, {"QualifierName": ["pathology"], "DescriptorName": "Obesity"}, {"QualifierName": ["toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Receptors, Bombesin"}, {"QualifierName": ["immunology"], "DescriptorName": "Respiratory Hypersensitivity"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gleason JA, Fagliano JA. Associations of daily pediatric asthma emergency department visits with air pollution in Newark, NJ: utilizing time-series and case-crossover study designs. J Asthma. 2015;52:815\u2013822.", "ArticleIdList": ["26211997"]}, {"Citation": "Gent JF, Triche EW, Holford TR, Belanger K, Bracken MB, Beckett WS, et al. Association of low-level ozone and fine particles with respiratory symptoms in children with asthma. JAMA. 2003;290:1859\u20131867.", "ArticleIdList": ["14532314"]}, {"Citation": "Devlin RB, McDonnell WF, Mann R, Becker S, House DE, Schreinemachers D, et al. Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am J Respir Cell Mol Biol. 1991;4:72\u201381.", "ArticleIdList": ["1846079"]}, {"Citation": "Foster WM, Brown RH, Macri K, Mitchell CS. Bronchial reactivity of healthy subjects: 18-20 h postexposure to ozone. J Appl Physiol (1985) 2000;89:1804\u20131810.", "ArticleIdList": ["11053329"]}, {"Citation": "Alexeeff SE, Litonjua AA, Suh H, Sparrow D, Vokonas PS, Schwartz J. Ozone exposure and lung function: effect modified by obesity and airways hyperresponsiveness in the VA normative aging study. Chest. 2007;132:1890\u20131897.", "ArticleIdList": ["17925423"]}, {"Citation": "Bennett WD, Hazucha MJ, Folinsbee LJ, Bromberg PA, Kissling GE, London SJ. Acute pulmonary function response to ozone in young adults as a function of body mass index. Inhal Toxicol. 2007;19:1147\u20131154.", "ArticleIdList": ["PMC2253725", "17987466"]}, {"Citation": "Dong GH, Qian Z, Liu MM, Wang D, Ren WH, Fu Q, et al. Obesity enhanced respiratory health effects of ambient air pollution in Chinese children: the Seven Northeastern Cities study. Int J Obes. 2013;37:94\u2013100.", "ArticleIdList": ["22846775"]}, {"Citation": "Ford ES. The epidemiology of obesity and asthma. J Allergy Clin Immunol. 2005;115:897\u2013909, quiz 910.", "ArticleIdList": ["15867841"]}, {"Citation": "Mathews JA, Krishnamoorthy N, Kasahara DI, Cho Y, Wurmbrand AP, Ribeiro L, et al. IL-33 drives augmented responses to ozone in obese mice. Environ Health Perspect. 2017;125:246\u2013253.", "ArticleIdList": ["PMC5289908", "27472835"]}, {"Citation": "Williams AS, Mathews JA, Kasahara DI, Chen L, Wurmbrand AP, Si H, et al. Augmented pulmonary responses to acute ozone exposure in obese mice: roles of TNFR2 and IL-13. Environ Health Perspect. 2013;121:551\u2013557.", "ArticleIdList": ["PMC3673194", "23434795"]}, {"Citation": "Mizutani N, Nabe T, Yoshino S. IL-17A promotes the exacerbation of IL-33-induced airway hyperresponsiveness by enhancing neutrophilic inflammation via CXCR2 signaling in mice. J Immunol. 2014;192:1372\u20131384.", "ArticleIdList": ["24446518"]}, {"Citation": "Kasahara DI, Mathews JA, Park CY, Cho Y, Hunt G, Wurmbrand AP, et al. ROCK insufficiency attenuates ozone-induced airway hyperresponsiveness in mice. Am J Physiol Lung Cell Mol Physiol. 2015;309:L736\u2013L746.", "ArticleIdList": ["PMC4593838", "26276827"]}, {"Citation": "Pichavant M, Goya S, Meyer EH, Johnston RA, Kim HY, Matangkasombut P, et al. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J Exp Med. 2008;205:385\u2013393.", "ArticleIdList": ["PMC2271004", "18250191"]}, {"Citation": "Z\u00fa\u00f1iga LA, Shen WJ, Joyce-Shaikh B, Pyatnova EA, Richards AG, Thom C, et al. IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol. 2010;185:6947\u20136959.", "ArticleIdList": ["PMC3001125", "21037091"]}, {"Citation": "Kim HY, Lee HJ, Chang YJ, Pichavant M, Shore SA, Fitzgerald KA, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54\u201361.", "ArticleIdList": ["PMC3912313", "24336249"]}, {"Citation": "Williams AS, Chen L, Kasahara DI, Si H, Wurmbrand AP, Shore SA. Obesity and airway responsiveness: role of TNFR2. Pulm Pharmacol Ther. 2013;26:444\u2013454.", "ArticleIdList": ["PMC3440516", "22584291"]}, {"Citation": "Mathews JA, Wurmbrand AP, Ribeiro L, Neto FL, Shore SA. Induction of IL-17a precedes development of airway hyperresponsiveness during diet-induced obesity and correlates with complement factor D. Front Immunol. 2014;5:440.", "ArticleIdList": ["PMC4164008", "25309539"]}, {"Citation": "Marijsse GS, Seys SF, Schelpe AS, Dilissen E, Goeminne P, Dupont LJ, et al. Obese individuals with asthma preferentially have a high IL-5/IL-17A/IL-25 sputum inflammatory pattern. Am J Respir Crit Care Med. 2014;189:1284\u20131285.", "ArticleIdList": ["24832749"]}, {"Citation": "Mathews JA, Williams AS, Brand JD, Wurmbrand AP, Chen L, Ninin FM, et al. \u03b3\u03b4 T cells are required for pulmonary IL-17A expression after ozone exposure in mice: role of TNF\u03b1. PLoS One. 2014;9:e97707.", "ArticleIdList": ["PMC4019643", "24823369"]}, {"Citation": "Che L, Jin Y, Zhang C, Lai T, Zhou H, Xia L, et al. Ozone-induced IL-17A and neutrophilic airway inflammation is orchestrated by the caspase-1-IL-1 cascade. Sci Rep. 2016;6:18680.", "ArticleIdList": ["PMC4703985", "26739627"]}, {"Citation": "Johnson DE, Georgieff MK. Pulmonary neuroendocrine cells: their secretory products and their potential roles in health and chronic lung disease in infancy. Am Rev Respir Dis. 1989;140:1807\u20131812.", "ArticleIdList": ["2574971"]}, {"Citation": "Shen N, Wang J, Zhao M, Pei F, He B. Anti-interleukin-17 antibodies attenuate airway inflammation in tobacco-smoke-exposed mice. Inhal Toxicol. 2011;23:212\u2013218.", "ArticleIdList": ["21456954"]}, {"Citation": "Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, et al. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature. 1985;316:823\u2013826.", "ArticleIdList": ["2993906"]}, {"Citation": "Avis IL, Kovacs TO, Kasprzyk PG, Treston AM, Bartholomew R, Walsh JH, et al. Preclinical evaluation of an anti-autocrine growth factor monoclonal antibody for treatment of patients with small-cell lung cancer. J Natl Cancer Inst. 1991;83:1470\u20131476.", "ArticleIdList": ["1656058"]}, {"Citation": "Siegfried JM, Krishnamachary N, Gaither Davis A, Gubish C, Hunt JD, Shriver SP. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer. Pulm Pharmacol Ther. 1999;12:291\u2013302.", "ArticleIdList": ["10545285"]}, {"Citation": "Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest. 2006;116:1218\u20131222.", "ArticleIdList": ["PMC1451213", "16670765"]}, {"Citation": "Sutton CE, Mielke LA, Mills KH. IL-17-producing \u03b3\u03b4 T cells and innate lymphoid cells. Eur J Immunol. 2012;42:2221\u20132231.", "ArticleIdList": ["22949320"]}, {"Citation": "Laan M, Cui ZH, Hoshino H, L\u00f6tvall J, Sj\u00f6strand M, Gruenert DC, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol. 1999;162:2347\u20132352.", "ArticleIdList": ["9973514"]}, {"Citation": "Kasahara DI, Kim HY, Mathews JA, Verbout NG, Williams AS, Wurmbrand AP, et al. Pivotal role of IL-6 in the hyperinflammatory responses to subacute ozone in adiponectin-deficient mice. Am J Physiol Lung Cell Mol Physiol. 2014;306:L508\u2013L520.", "ArticleIdList": ["PMC3949085", "24381131"]}, {"Citation": "Kasahara DI, Kim HY, Williams AS, Verbout NG, Tran J, Si H, et al. Pulmonary inflammation induced by subacute ozone is augmented in adiponectin-deficient mice: role of IL-17A. J Immunol. 2012;188:4558\u20134567.", "ArticleIdList": ["PMC3345205", "22474022"]}, {"Citation": "Vasu VT, Oommen S, Lim Y, Valacchi G, Hobson B, Eirserich JP, et al. Modulation of ozone-sensitive genes in \u03b1-tocopherol transfer protein null mice. Inhal Toxicol. 2010;22:1\u201316.", "ArticleIdList": ["PMC2805035", "19555225"]}, {"Citation": "Williams AS, Issa R, Leung SY, Nath P, Ferguson GD, Bennett BL, et al. Attenuation of ozone-induced airway inflammation and hyper-responsiveness by c-Jun NH2 terminal kinase inhibitor SP600125. J Pharmacol Exp Ther. 2007;322:351\u2013359.", "ArticleIdList": ["17460151"]}, {"Citation": "Benderdour M, Tardif G, Pelletier JP, Di Battista JA, Reboul P, Ranger P, et al. Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1\u03b2. J Rheumatol. 2002;29:1262\u20131272.", "ArticleIdList": ["12064845"]}, {"Citation": "Lach E, Haddad EB, Gies JP. Contractile effect of bombesin on guinea pig lung in vitro: involvement of gastrin-releasing peptide-preferring receptors. Am J Physiol. 1993;264:L80\u2013L86.", "ArticleIdList": ["8381599"]}, {"Citation": "Chang LY, Subramaniam M, Yoder BA, Day BJ, Ellison MC, Sunday ME, et al. A catalytic antioxidant attenuates alveolar structural remodeling in bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2003;167:57\u201364.", "ArticleIdList": ["12502477"]}, {"Citation": "Deterding RR, Pye C, Fan LL, Langston C. Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia. Pediatr Pulmonol. 2005;40:157\u2013165.", "ArticleIdList": ["15965897"]}, {"Citation": "Oliveira PG, Grespan R, Pinto LG, Meurer L, Brenol JC, Roesler R, et al. Protective effect of RC-3095, an antagonist of the gastrin-releasing peptide receptor, in experimental arthritis. Arthritis Rheum. 2011;63:2956\u20132965.", "ArticleIdList": ["21953084"]}, {"Citation": "Lajoie S, Lewkowich IP, Suzuki Y, Clark JR, Sproles AA, Dienger K, et al. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat Immunol. 2010;11:928\u2013935.", "ArticleIdList": ["PMC2943538", "20802484"]}, {"Citation": "Aguayo SM, Kane MA, King TE, Jr, Schwarz MI, Grauer L, Miller YE. Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic cigarette smokers. J Clin Invest. 1989;84:1105\u20131113.", "ArticleIdList": ["PMC329766", "2794048"]}, {"Citation": "Degan S, Lopez GY, Kevill K, Sunday ME. Gastrin-releasing peptide, immune responses, and lung disease. Ann NY Acad Sci. 2008;1144:136\u2013147.", "ArticleIdList": ["19076373"]}, {"Citation": "Czepielewski RS, Porto BN, Rizzo LB, Roesler R, Abujamra AL, Pinto LG, et al. Gastrin-releasing peptide receptor (GRPR) mediates chemotaxis in neutrophils. Proc Natl Acad Sci USA. 2012;109:547\u2013552.", "ArticleIdList": ["PMC3258617", "22203955"]}, {"Citation": "Meloni F, Ballabio P, Bianchi L, Mangiarotti P, Grassi G, Bignamini A, et al. Bombesin enhances monocyte and macrophage activities: possible role in the modulation of local pulmonary defenses in chronic bronchitis. Respiration. 1996;63:28\u201334.", "ArticleIdList": ["8833990"]}, {"Citation": "McAllister F, Henry A, Kreindler JL, Dubin PJ, Ulrich L, Steele C, et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol. 2005;175:404\u2013412.", "ArticleIdList": ["PMC2849297", "15972674"]}, {"Citation": "Barin JG, Baldeviano GC, Talor MV, Wu L, Ong S, Quader F, et al. Macrophages participate in IL-17-mediated inflammation. Eur J Immunol. 2012;42:726\u2013736.", "ArticleIdList": ["PMC4292791", "22161142"]}, {"Citation": "Zhang M, Fei X, Zhang GQ, Zhang PY, Li F, Bao WP, et al. Role of neutralizing anti-murine interleukin-17a monoclonal antibody on chronic ozone-induced airway inflammation in mice. Biomed Pharmacother. 2016;83:247\u2013256.", "ArticleIdList": ["27380433"]}, {"Citation": "Shore SA, Williams ES, Chen L, Benedito LA, Kasahara DI, Zhu M. Impact of aging on pulmonary responses to acute ozone exposure in mice: role of TNFR1. Inhal Toxicol. 2011;23:878\u2013888.", "ArticleIdList": ["PMC3359651", "22066571"]}, {"Citation": "Hatch GE, Slade R, Harris LP, McDonnell WF, Devlin RB, Koren HS, et al. Ozone dose and effect in humans and rats: a comparison using oxygen-18 labeling and bronchoalveolar lavage. Am J Respir Crit Care Med. 1994;150:676\u2013683.", "ArticleIdList": ["8087337"]}, {"Citation": "Akinbami LJ, Fryar CD. Current asthma prevalence by weight status among adults: United States, 2001\u20132014. NCHS Data Brief. 2016;(239)", "ArticleIdList": ["27019018"]}, {"Citation": "Ishikawa-Brush Y, Powell JF, Bolton P, Miller AP, Francis F, Willard HF, et al. Autism and multiple exostoses associated with an X;8 translocation occurring within the GRPR gene and 3\u2032 to the SDC2 gene. Hum Mol Genet. 1997;6:1241\u20131250.", "ArticleIdList": ["9259269"]}, {"Citation": "Shriver SP, Bourdeau HA, Gubish CT, Tirpak DL, Davis AL, Luketich JD, et al. Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. J Natl Cancer Inst. 2000;92:24\u201333.", "ArticleIdList": ["10620630"]}, {"Citation": "Busse WW, Holgate S, Kerwin E, Chon Y, Feng J, Lin J, et al. Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am J Respir Crit Care Med. 2013;188:1294\u20131302.", "ArticleIdList": ["24200404"]}], "ReferenceList": []}], "History": [{"Year": "2017", "Month": "9", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "9", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28957638", "PMC5854955", "10.1165/rcmb.2017-0071OC"]}}], "PubmedBookArticle": []}